J. Safra Asset Management’s Janux Therapeutics JANX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$324 Hold
14
﹤0.01% 316
2025
Q1
$378 Buy
14
+4
+40% +$108 ﹤0.01% 293
2024
Q4
$525 Buy
10
+3
+43% +$158 ﹤0.01% 324
2024
Q3
$324 Buy
+7
New +$324 ﹤0.01% 296